Central Admixture Pharmacy Services Inc: Drug Recall

Recall #D-1060-2023 · 07/17/2023

Class II: Risk

Recall Details

Recall Number: D-1060-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Central Admixture Pharmacy Services Inc
Status: Terminated
Date Initiated: 07/17/2023
Location: San Diego, CA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 5,259 syringes

Reason for Recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Product Description

HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1

Distribution Pattern

Nationwide in the USA

Other Recalls by Central Admixture Pharmacy Services Inc

Class I: Dangerous 02/20/2025

Presence of Particulate Matter
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:

View all recalls by Central Admixture Pharmacy Services Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.